{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:25:48Z","timestamp":1793683548239,"version":"4.5.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012895","name":"Zoetis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.tvjl.2026.106909","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:30:16Z","timestamp":1790955016000},"page":"106909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and safety of relfovetmab administered every three months for the treatment of pain associated with osteoarthritis in client-owned cats"],"prefix":"10.1016","volume":"320","author":[{"given":"Csilla","family":"Becskei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halima","family":"Cheritel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guncha","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2218-9361","authenticated-orcid":false,"given":"Bernard D.","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7472-4095","authenticated-orcid":false,"given":"Adam","family":"Werts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Escalada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.","family":"Cleaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9755-7279","authenticated-orcid":false,"given":"Gina","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tvjl.2026.106909_bib1","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1038\/s41598-021-87023-2","article-title":"Robenacoxib shows efficacy for the treatment of chronic degenerative joint disease-associated pain in cats: a randomized and blinded pilot clinical trial","volume":"11","author":"Adrian","year":"2021","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.tvjl.2026.106909_bib2","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1136\/annrheumdis-2013-203416","article-title":"Augmented pain behavioural responses to intra-articular injection of nerve growth factor in two animal models of osteoarthritis","volume":"73","author":"Ashraf","year":"2014","journal-title":"Annals of the Rheuma"},{"issue":"2","key":"10.1016\/j.tvjl.2026.106909_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/cpt.20","article-title":"Biologics in the treatment of chronic pain: a new era of therapy?","volume":"97","author":"Bannwarth","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tvjl.2026.106909_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tvjl.2018.07.010","article-title":"Assessment of quality of life and chronic pain in dogs","volume":"239","author":"Belshaw","year":"2018","journal-title":"Vet. J."},{"issue":"8","key":"10.1016\/j.tvjl.2026.106909_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1748-5827.2006.00143.x","article-title":"Feline osteoarthritis: a prospective study of 28 cases","volume":"47","author":"Clarke","year":"2006","journal-title":"J. Small. Anim. Pract."},{"issue":"6","key":"10.1016\/j.tvjl.2026.106909_bib6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.vaa.2021.08.001","article-title":"A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis","volume":"48","author":"Corral","year":"2021","journal-title":"Vet. Anaesth. Analg."},{"issue":"1","key":"10.1016\/j.tvjl.2026.106909_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/vr.104590","article-title":"Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats","volume":"184","author":"Enomoto","year":"2019","journal-title":"Vet. Rec."},{"key":"10.1016\/j.tvjl.2026.106909_bib8","unstructured":"European Medicines Agency, 2010. Meloxicam (meloxidyl) summary of product characteristics. https:\/\/ec.europa.eu\/health\/documents\/community-register\/2019\/20190111143408\/anx_143408_en.pdf (accessed 26 May 2025)."},{"key":"10.1016\/j.tvjl.2026.106909_bib9","unstructured":"European Medicines Agency, 2018. Robenocoxib (onsior) summary of product characteristics. https:\/\/ec.europa.eu\/health\/documents\/community-register\/2018\/20180803142040\/anx_142040_en.pdf (accessed 26 May 2025)."},{"key":"10.1016\/j.tvjl.2026.106909_bib10","unstructured":"European Medicines Agency, 2020. Librela (bedinvetmab). https:\/\/medicines.health.europa.eu\/veterinary\/en\/600000001761 (accessed 6 July 2025)."},{"key":"10.1016\/j.tvjl.2026.106909_bib11","unstructured":"European Medicines Agency, 2021. Solensia (frunevetmab). https:\/\/medicines.health.europa.eu\/veterinary\/en\/600000001994 (accessed 9 January 2026)."},{"key":"10.1016\/j.tvjl.2026.106909_bib12","unstructured":"Food and Drug Administration, 2022. Solensia (frunevetmab injection) freedom of information summary. https:\/\/animaldrugsatfda.fda.gov\/adafda\/app\/search\/public\/document\/downloadFoi\/11817 (accessed 26 May 2025)."},{"key":"10.1016\/j.tvjl.2026.106909_bib13","unstructured":"Food and Drug Administration, 2023. Librela (bedinvetmab injection) freedom of information summary. https:\/\/animaldrugsatfda.fda.gov\/adafda\/app\/search\/public\/document\/downloadFoi\/13959 (accessed 26 May 2025)."},{"issue":"9","key":"10.1016\/j.tvjl.2026.106909_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1748-5827.2005.tb00340.x","article-title":"Osteoarthritis in cats: A retrospective radiological study","volume":"46","author":"Godfrey","year":"2005","journal-title":"J. Small. Anim. Pract."},{"issue":"2","key":"10.1016\/j.tvjl.2026.106909_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jvim.12312","article-title":"Detection of clinically relevant pain relief in cats with degenerative joint disease associated pain","volume":"28","author":"Gruen","year":"2014","journal-title":"J. Vet. Intern. Med."},{"issue":"7","key":"10.1016\/j.tvjl.2026.106909_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131839","article-title":"Criterion validation testing of clinical metrology instruments for measuring degenerative joint disease associated mobility impairment in cats","volume":"10","author":"Gruen","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.tvjl.2026.106909_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5326\/JAAHA-MS-7292","article-title":"2022 aaha pain management guidelines for dogs and cats","volume":"58","author":"Gruen","year":"2022","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"10.1016\/j.tvjl.2026.106909_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.610028","article-title":"Efficacy and safety of an anti-nerve growth factor antibody (frunevetmab) for the treatment of degenerative joint disease-associated chronic pain in cats: a multisite pilot field study","volume":"8","author":"Gruen","year":"2021","journal-title":"Front Vet. Sci."},{"issue":"6","key":"10.1016\/j.tvjl.2026.106909_bib19","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1111\/jvim.16291","article-title":"Frunevetmab, a felinized anti-nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats","volume":"35","author":"Gruen","year":"2021","journal-title":"J. Vet. Intern. Med."},{"issue":"4","key":"10.1016\/j.tvjl.2026.106909_bib20","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/jvim.13972","article-title":"A feline-specific anti-nerve growth factor antibody improves mobility in cats with degenerative joint disease-associated pain: a pilot proof of concept study","volume":"30","author":"Gruen","year":"2016","journal-title":"J. Vet. Intern. Med."},{"issue":"5","key":"10.1016\/j.tvjl.2026.106909_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2460\/javma.252.5.565","article-title":"Evaluation of tramadol for treatment of osteoarthritis in geriatric cats","volume":"252","author":"Guedes","year":"2018","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"5","key":"10.1016\/j.tvjl.2026.106909_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2460\/javma.253.5.579","article-title":"Assessment of the effects of gabapentin on activity levels and owner-perceived mobility impairment and quality of life in osteoarthritic geriatric cats","volume":"253","author":"Guedes","year":"2018","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"3","key":"10.1016\/j.tvjl.2026.106909_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ani13030392","article-title":"Broadening the veterinary consultation: dog owners want to talk about more than physical health","volume":"13","author":"Hale","year":"2023","journal-title":"Animals"},{"key":"10.1016\/j.tvjl.2026.106909_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2025.1502218","article-title":"A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis","volume":"12","author":"Innes","year":"2025","journal-title":"Front. Vet. Sci."},{"issue":"4","key":"10.1016\/j.tvjl.2026.106909_bib25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3415\/VCOT-10-04-0051","article-title":"Nerve growth factor concentrations in the synovial fluid from healthy dogs and dogs with secondary osteoarthritis","volume":"24","author":"Isola","year":"2011","journal-title":"Vet. Comp. Orthop. Traumatol."},{"key":"10.1016\/j.tvjl.2026.106909_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2020.105579","article-title":"Nerve growth factor in the equine joint","volume":"267","author":"Kendall","year":"2021","journal-title":"Vet. J."},{"issue":"5","key":"10.1016\/j.tvjl.2026.106909_bib27","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1111\/jvim.16148","article-title":"Clinical safety of robenacoxib in cats with chronic musculoskeletal disease","volume":"35","author":"King","year":"2021","journal-title":"J. Vet. Intern. Med."},{"issue":"3","key":"10.1016\/j.tvjl.2026.106909_bib28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1939-1676.2007.tb02983.x","article-title":"Evaluation of client-specific outcome measures and activity monitoring to measure pain relief in cats with osteoarthritis","volume":"21","author":"Lascelles","year":"2007","journal-title":"J. Vet. Intern. Med."},{"issue":"5","key":"10.1016\/j.tvjl.2026.106909_bib29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1532-950X.2010.00708.x","article-title":"Cross-sectional study of the prevalence of radiographic degenerative joint disease in domesticated cats","volume":"39","author":"Lascelles","year":"2010","journal-title":"Vet. Surg."},{"key":"10.1016\/j.tvjl.2026.106909_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tvjl.2019.07.001","article-title":"Measurement of chronic pain in companion animals: discussions from the pain in animals workshop (paw) 2017","volume":"250","author":"Lascelles","year":"2019","journal-title":"Vet. J."},{"issue":"6","key":"10.1016\/j.tvjl.2026.106909_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/1098612X13511446","article-title":"Prevalence and classification of chronic kidney disease in cats randomly selected from four age groups and in cats recruited for degenerative joint disease studies","volume":"16","author":"Marino","year":"2014","journal-title":"J. Feline. Med. Surg."},{"issue":"5","key":"10.1016\/j.tvjl.2026.106909_bib32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.vaa.2023.06.003","article-title":"A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the united states of america evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody","volume":"50","author":"Michels","year":"2023","journal-title":"Vet. Anaesth. Analg."},{"issue":"6","key":"10.1016\/j.tvjl.2026.106909_bib33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/vaa.12360","article-title":"Analgesic efficacy of an oral transmucosal spray formulation of meloxicam alone or in combination with tramadol in cats with naturally occurring osteoarthritis","volume":"43","author":"Monteiro","year":"2016","journal-title":"Vet. Anaesth. Analg."},{"issue":"4","key":"10.1016\/j.tvjl.2026.106909_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175565","article-title":"Analgesic efficacy of tramadol in cats with naturally occurring osteoarthritis","volume":"12","author":"Monteiro","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.tvjl.2026.106909_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/jsap.13566","article-title":"2022 wsava guidelines for the recognition, assessment and treatment of pain","volume":"64","author":"Monteiro","year":"2023","journal-title":"J. Small Animal Practice."},{"issue":"7","key":"10.1016\/j.tvjl.2026.106909_bib36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1177\/1098612X19856179","article-title":"Chronic pain in cats: recent advances in clinical assessment","volume":"21","author":"Monteiro","year":"2019","journal-title":"J. Feline. Med. Surg."},{"issue":"4","key":"10.1016\/j.tvjl.2026.106909_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183873","article-title":"Neuropilin-1 inhibition suppresses nerve growth factor signaling and nociception in pain models","volume":"135","author":"Peach","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.tvjl.2026.106909_bib38","doi-asserted-by":"crossref","first-page":"688","DOI":"10.2460\/ajvr.77.7.688","article-title":"Safety and toxicokinetic profiles associated with daily oral administration of grapiprant, a selective antagonist of the prostaglandin e2 ep4 receptor, to cats","volume":"77","author":"Rausch-Derra","year":"2016","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.tvjl.2026.106909_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2024.1395360","article-title":"Measuring the effect of the anti-nerve growth factor antibodies bedinvetmab and frunevetmab on quality of life in dogs and cats with osteoarthritis using a validated health-related quality of life outcome measure: an observational real-world study","volume":"11","author":"Reid","year":"2024","journal-title":"Front. Vet. Sci."},{"issue":"6","key":"10.1016\/j.tvjl.2026.106909_bib40","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/1098612X20967639","article-title":"Owner evaluation of quality of life and mobility in osteoarthritic cats treated with amantadine or placebo","volume":"23","author":"Shipley","year":"2021","journal-title":"J. Feline. Med. Surg."},{"issue":"10","key":"10.1016\/j.tvjl.2026.106909_bib41","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/vr.103991","article-title":"Difficulties in administration of oral medication formulations to pet cats: an e-survey of cat owners","volume":"180","author":"Siven","year":"2017","journal-title":"Vet. Rec."},{"issue":"3","key":"10.1016\/j.tvjl.2026.106909_bib42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tvjl.2009.12.014","article-title":"Cross-sectional study of the prevalence and clinical features of osteoarthritis in 100 cats","volume":"187","author":"Slingerland","year":"2011","journal-title":"Vet. J."},{"issue":"1","key":"10.1016\/j.tvjl.2026.106909_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/1098612X18808103","article-title":"Acute pain in cats: Recent advances in clinical assessment","volume":"21","author":"Steagall","year":"2019","journal-title":"J. Feline. Med. Surg."},{"issue":"4","key":"10.1016\/j.tvjl.2026.106909_bib44","doi-asserted-by":"crossref","DOI":"10.1177\/1098612X241241951","article-title":"2024 isfm and aafp consensus guidelines on the long-term use of nsaids in cats","volume":"26","author":"Taylor","year":"2024","journal-title":"J. Feline. Med. Surg."},{"key":"10.1016\/j.tvjl.2026.106909_bib45","unstructured":"The European Agency for the Evaluation of Medicinal Products 2000. Vich topic gl9. Guideline on good clinical practices. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/vich-gl9-good-clinical-practices-step-7_en.pdf (accessed 13 November 2025)."},{"key":"10.1016\/j.tvjl.2026.106909_bib46","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration (January 2019) Immunogenicity Testing of Therapeutic Protein Products \u2014 Developing and Validating Assays for Anti-Drug Antibody Detection (Accessed 27 February 2026)."},{"issue":"10","key":"10.1016\/j.tvjl.2026.106909_bib47","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/rheumatology\/keq188","article-title":"Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis","volume":"49","author":"Walsh","year":"2010","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.tvjl.2026.106909_bib48","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s004180000222","article-title":"Immunohistochemical study of ngf and its receptors in the synovial membrane of the ankle joint of adjuvant-induced arthritic rats","volume":"114","author":"Wu","year":"2000","journal-title":"Histochem. Cell Biol."}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326003667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023326003667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:27:10Z","timestamp":1793680030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023326003667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":48,"alternative-id":["S1090023326003667"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106909","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of relfovetmab administered every three months for the treatment of pain associated with osteoarthritis in client-owned cats","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2026.106909","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106909"}}